, NGN HESI RN PHARMACOLOGY VERSION 1 NEWEST
2026-2027 WITH COMPLETE ALL QUESTIONS AND
CORRECT DETAILED ANSWERS BRAND NEW VERSION!
130 QUESTIONS
TABLE OF CONTENTS
# TOPIC
1 Demonstrate mastery of core concepts
2 NGN HESI RN PHARMACOLOGY Version 1 Newest 2026
3 2027 With Complete All Questions And Correct Detailed Answers Brand New Version!
4 Foundations of NGN HESI RN PHARMACOLOGY Version 1 Newest 2026-2027 With Complete All
Questions And Correct Detailed Answers Brand New Version!
5 Applied NGN HESI RN PHARMACOLOGY Version 1 Newest 2026-2027 With Complete All Questions
And Correct Detailed Answers Brand New Version!
6 Advanced NGN HESI RN PHARMACOLOGY Version 1 Newest 2026-2027 With Complete All Questions
And Correct Detailed Answers Brand New Version!
7 NGN HESI RN PHARMACOLOGY Version 1 Newest 2026-2027 With Complete All Questions And
Correct Detailed Answers Brand New Version! Review
Q1 DEMONSTRATE MASTERY OF CORE CONCEPTS
A patient on warfarin for mechanical heart valve develops acute DVT. Therapeutic
INR is 2.5. Which anticoagulant strategy is most appropriate?
A. Hold warfarin and start IV unfractionated heparin
B. Start enoxaparin without bridging, continue warfarin CORRECT
C. Continue warfarin alone, no additional therapy
D. Start rivaroxaban and stop warfarin
RATIONALE: For DVT in a patient already therapeutic on warfarin, continuing warfarin alone is
sufficient; additional anticoagulation is not needed. IV heparin would be excessive, and
rivaroxaban is not indicated when warfarin is therapeutic.
Page 1
,Q2 DEMONSTRATE MASTERY OF CORE CONCEPTS
A patient on digoxin presents with fatigue, nausea, and blurred vision. ECG shows
new-onset atrial fibrillation with slow ventricular rate. Which intervention is most
appropriate?
A. Administer digoxin immune Fab CORRECT
B. Increase digoxin dose to control rate
C. Start amiodarone for rhythm control
D. Administer potassium chloride IV
RATIONALE: Symptoms and new AF with slow rate suggest digoxin toxicity; digoxin immune Fab
is indicated. Increasing dose worsens toxicity; amiodarone can increase digoxin levels;
potassium may be given if hypokalemic but not without knowing levels.
Q3 DEMONSTRATE MASTERY OF CORE CONCEPTS
A patient with type 2 diabetes and chronic kidney disease (eGFR 30 mL/min) is
being started on metformin. What is the most appropriate action?
A. Start metformin at a reduced dose with monitoring CORRECT
B. Avoid metformin and use sulfonylurea instead
C. Start metformin at full dose with close monitoring
D. Use metformin only if eGFR is >60
RATIONALE: Metformin can be used in CKD with eGFR 30-45 with dose reduction and
monitoring; it is contraindicated below 30. Sulfonylureas carry hypoglycemia risk; full dose is
unsafe; option D is outdated.
Page 2
, Q4 DEMONSTRATE MASTERY OF CORE CONCEPTS
A patient on stable doses of phenytoin and warfarin develops new-onset seizures.
Phenytoin level is subtherapeutic. What is the most likely cause?
A. Phenytoin induced warfarin metabolism
B. Warfarin displaced phenytoin from protein binding
C. Phenytoin autoinduction decreased its own level CORRECT
D. Warfarin increased phenytoin clearance
RATIONALE: Phenytoin exhibits autoinduction, increasing its own metabolism over time, lowering
levels. Warfarin does not significantly affect phenytoin levels; protein binding displacement is
transient; phenytoin induces warfarin metabolism, not vice versa.
Q5 DEMONSTRATE MASTERY OF CORE CONCEPTS
A patient on lithium presents with tremor, confusion, and ataxia. Lithium level is
2.5 mEq/L. Which intervention is most appropriate?
A. Administer activated charcoal
B. Start hemodialysis CORRECT
C. Administer sodium polystyrene sulfonate
D. Hold lithium and recheck level in 12 hours
RATIONALE: Severe lithium toxicity with neurologic symptoms requires hemodialysis. Activated
charcoal does not bind lithium; sodium polystyrene is for hyperkalemia; holding lithium alone is
insufficient for severe toxicity.
Page 3
2026-2027 WITH COMPLETE ALL QUESTIONS AND
CORRECT DETAILED ANSWERS BRAND NEW VERSION!
130 QUESTIONS
TABLE OF CONTENTS
# TOPIC
1 Demonstrate mastery of core concepts
2 NGN HESI RN PHARMACOLOGY Version 1 Newest 2026
3 2027 With Complete All Questions And Correct Detailed Answers Brand New Version!
4 Foundations of NGN HESI RN PHARMACOLOGY Version 1 Newest 2026-2027 With Complete All
Questions And Correct Detailed Answers Brand New Version!
5 Applied NGN HESI RN PHARMACOLOGY Version 1 Newest 2026-2027 With Complete All Questions
And Correct Detailed Answers Brand New Version!
6 Advanced NGN HESI RN PHARMACOLOGY Version 1 Newest 2026-2027 With Complete All Questions
And Correct Detailed Answers Brand New Version!
7 NGN HESI RN PHARMACOLOGY Version 1 Newest 2026-2027 With Complete All Questions And
Correct Detailed Answers Brand New Version! Review
Q1 DEMONSTRATE MASTERY OF CORE CONCEPTS
A patient on warfarin for mechanical heart valve develops acute DVT. Therapeutic
INR is 2.5. Which anticoagulant strategy is most appropriate?
A. Hold warfarin and start IV unfractionated heparin
B. Start enoxaparin without bridging, continue warfarin CORRECT
C. Continue warfarin alone, no additional therapy
D. Start rivaroxaban and stop warfarin
RATIONALE: For DVT in a patient already therapeutic on warfarin, continuing warfarin alone is
sufficient; additional anticoagulation is not needed. IV heparin would be excessive, and
rivaroxaban is not indicated when warfarin is therapeutic.
Page 1
,Q2 DEMONSTRATE MASTERY OF CORE CONCEPTS
A patient on digoxin presents with fatigue, nausea, and blurred vision. ECG shows
new-onset atrial fibrillation with slow ventricular rate. Which intervention is most
appropriate?
A. Administer digoxin immune Fab CORRECT
B. Increase digoxin dose to control rate
C. Start amiodarone for rhythm control
D. Administer potassium chloride IV
RATIONALE: Symptoms and new AF with slow rate suggest digoxin toxicity; digoxin immune Fab
is indicated. Increasing dose worsens toxicity; amiodarone can increase digoxin levels;
potassium may be given if hypokalemic but not without knowing levels.
Q3 DEMONSTRATE MASTERY OF CORE CONCEPTS
A patient with type 2 diabetes and chronic kidney disease (eGFR 30 mL/min) is
being started on metformin. What is the most appropriate action?
A. Start metformin at a reduced dose with monitoring CORRECT
B. Avoid metformin and use sulfonylurea instead
C. Start metformin at full dose with close monitoring
D. Use metformin only if eGFR is >60
RATIONALE: Metformin can be used in CKD with eGFR 30-45 with dose reduction and
monitoring; it is contraindicated below 30. Sulfonylureas carry hypoglycemia risk; full dose is
unsafe; option D is outdated.
Page 2
, Q4 DEMONSTRATE MASTERY OF CORE CONCEPTS
A patient on stable doses of phenytoin and warfarin develops new-onset seizures.
Phenytoin level is subtherapeutic. What is the most likely cause?
A. Phenytoin induced warfarin metabolism
B. Warfarin displaced phenytoin from protein binding
C. Phenytoin autoinduction decreased its own level CORRECT
D. Warfarin increased phenytoin clearance
RATIONALE: Phenytoin exhibits autoinduction, increasing its own metabolism over time, lowering
levels. Warfarin does not significantly affect phenytoin levels; protein binding displacement is
transient; phenytoin induces warfarin metabolism, not vice versa.
Q5 DEMONSTRATE MASTERY OF CORE CONCEPTS
A patient on lithium presents with tremor, confusion, and ataxia. Lithium level is
2.5 mEq/L. Which intervention is most appropriate?
A. Administer activated charcoal
B. Start hemodialysis CORRECT
C. Administer sodium polystyrene sulfonate
D. Hold lithium and recheck level in 12 hours
RATIONALE: Severe lithium toxicity with neurologic symptoms requires hemodialysis. Activated
charcoal does not bind lithium; sodium polystyrene is for hyperkalemia; holding lithium alone is
insufficient for severe toxicity.
Page 3
